Log in to save to my catalogue

CD33 Alzheimer's disease locus: altered monocyte function and amyloid biology

CD33 Alzheimer's disease locus: altered monocyte function and amyloid biology

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3703870

CD33 Alzheimer's disease locus: altered monocyte function and amyloid biology

About this item

Full title

CD33 Alzheimer's disease locus: altered monocyte function and amyloid biology

Publisher

New York: Nature Publishing Group US

Journal title

Nature neuroscience, 2013-07, Vol.16 (7), p.848-850

Language

English

Formats

Publication information

Publisher

New York: Nature Publishing Group US

More information

Scope and Contents

Contents

Genome-wide association studies have identified
CD33
as an Alzheimer's disease susceptibility locus. Here, the authors show that the
CD33
risk allele is associated with altered myeloid function, microglial activation and
in vivo
amyloid pathology.
In our functional dissection of the
CD33
Alzheimer's disease susceptibility...

Alternative Titles

Full title

CD33 Alzheimer's disease locus: altered monocyte function and amyloid biology

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3703870

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3703870

Other Identifiers

ISSN

1097-6256

E-ISSN

1546-1726

DOI

10.1038/nn.3435

How to access this item